Try our Advanced Search for more refined results
May 17, 2017
JANSSEN BIOTECH, INC. v. SAMSUNG BIOEPIS CO., LTD.
Case Number:
2:17-cv-03524
Court:
Nature of Suit:
Judge:
Firms
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 14, 2017
Janssen, Samsung Subsidiary Drop Suit Over Remicade Copy
A Johnson & Johnson subsidiary dropped its infringement lawsuit against Samsung Bioepis Co. Ltd. over a patent on its arthritis-treating biologic Remicade, with the parties agreeing in New Jersey federal court to dismiss all remaining claims, some with prejudice.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login